Jamie Stobo
Dundee, SCT, United Kingdom
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 18 publications
The frequent exacerbator phenotype in bronchiectasis revisited: Data from EMBARC registry.
Journal: American journal of respiratory and critical care medicine
Published: April 01, 2026
Correction: Relative telomere length and senescence-associated inflammatory cytokines as blood-based prognostic markers in patients with advanced or resectable gastro-oesophageal adenocarcinoma.
Journal: British journal of cancer
Published: December 19, 2025
Reply to Tang and Sun, and to Deng and Liu.
Journal: American journal of respiratory and critical care medicine
Published: September 15, 2025
Endotypes of Pseudomonas aeruginosa Infection in Bronchiectasis Are Associated with Inhaled Antibiotic Response: Results from Two Randomized, Double-Blind, Placebo-controlled Phase III Trials (ORBIT 3 and ORBIT 4).
Journal: American journal of respiratory and critical care medicine
Published: July 15, 2025
Design and rationale of the AIR-NET trial: a randomised, open-label, multifactorial, multicentre, adaptive platform trial using a range of repurposed anti-inflammatory treatments to improve outcomes in patients with bronchiectasis within the EMBARC clinical research network.
Journal: ERJ open research
Published: May 02, 2025
Relative telomere length and senescence-associated inflammatory cytokines as blood-based prognostic markers in patients with advanced or resectable gastro-oesophageal adenocarcinoma.
Journal: British journal of cancer
Published: April 10, 2025
Azurocidin-1 as a mediator of bronchiectasis severity, epithelial defence, and target of dipeptidyl peptidase-1 inhibition: an international, multicohort study.
Journal: The Lancet. Respiratory medicine
Published: March 11, 2025
Broad Immunomodulatory Effects of the Dipeptidyl Peptidase-1 Inhibitor Brensocatib in Bronchiectasis: Data from the Phase 2, Double-Blind, Placebo-controlled WILLOW Trial.
Journal: American journal of respiratory and critical care medicine
Published: February 12, 2025
Investigating the impact of dipeptidyl peptidase-1 inhibition in humans using multi-omics.
Journal: The Journal of allergy and clinical immunology
Published: February 11, 2025
Symptoms, risk of future exacerbations, and response to long-term macrolide treatment in bronchiectasis: an observational study.
Journal: The Lancet. Respiratory medicine
Published: October 16, 2024
Concurrent Olaparib and Radiation Therapy in Older Patients With Newly Diagnosed Glioblastoma: The Phase 1 Dose-Escalation PARADIGM Trial.
Journal: International journal of radiation oncology, biology, physics
Published: October 18, 2023
Last Updated: 09/26/2026